Mayne Pharma Group Limited announced the commencement of promotion of Fabior® (tazarotene) Foam, 0.1% and Sorilux® (calcipotriene) Foam, 0.005% in the United States by Mayne Pharma's Specialty Brands division. Fabior is a patent-protected foam product indicated for the topical treatment of acne.